# Cassava Sciences Inc. (SAVA)

Source: https://www.quantisnow.com/company/SAVA
Generated: 2026-11-15T11:48:59.276Z

- Ticker: SAVA
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: cassavasciences.com

## About

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.

## Latest SAVA news and filings

- 2026-03-12 20:01 UTC [SEC Form 10-K] [SEC Form 10-K filed by Cassava Sciences Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-cassava-sciences-inc-6444260)
- 2026-03-12 12:15 UTC [SEC Form 8-K] [Cassava Sciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cassava-sciences-inc-filed-sec-form-8-k-results-of-operations-6443586)
- 2026-03-10 12:15 UTC [SEC Form 8-K] [Cassava Sciences Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cassava-sciences-inc-filed-sec-form-8-k-amendments-to-articles-6438784)
- 2026-03-10 12:00 UTC [Cassava Sciences Announces Name Change to Filana Therapeutics, Inc.](https://www.quantisnow.com/insight/cassava-sciences-announces-name-change-to-filana-therapeutics-inc-6438683)
- 2026-02-19 13:15 UTC [SEC Form 8-K] [Cassava Sciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cassava-sciences-inc-filed-sec-form-8-k-regulation-fd-disclosure-6401498)
- 2026-02-19 13:00 UTC [Cassava Announces Closure of U.S. Department of Justice Investigation](https://www.quantisnow.com/insight/cassava-announces-closure-of-us-department-of-justice-investigation-6401421)
- 2026-01-13 13:00 UTC [Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer's Disease in the Journal of Prevention of Alzheimer's Disease](https://www.quantisnow.com/insight/cassava-announces-publication-of-peer-reviewed-phase-3-results-for-simufilam-6347384)
- 2025-12-23 13:46 UTC [SEC Form 8-K] [Cassava Sciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement](https://www.quantisnow.com/insight/cassava-sciences-inc-filed-sec-form-8-k-entry-into-a-6326317)
- 2025-12-22 21:09 UTC [SEC Form 8-K] [Amendment: SEC Form 8-K/A filed by Cassava Sciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-8-ka-filed-by-cassava-sciences-inc-6325311)
- 2025-12-18 22:02 UTC [SEC Form 8-K] [Cassava Sciences Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/cassava-sciences-inc-filed-sec-form-8-k-other-events-6322522)
- 2025-12-17 21:12 UTC [SEC Form 8-K] [Cassava Sciences Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cassava-sciences-inc-filed-sec-form-8-k-leadership-update-financial-6319976)
- 2025-12-08 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Cassava Sciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-cassava-sciences-inc-6306029)
- 2025-12-03 11:27 UTC [SEC Form 8-K] [Cassava Sciences Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/cassava-sciences-inc-filed-sec-form-8-k-other-events-6300614)
- 2025-11-25 21:06 UTC [Insider Buy] [Director Anderson Robert Eugene Jr bought $24,940 worth of shares (8,600 units at $2.90) (SEC Form 4)](https://www.quantisnow.com/insight/director-anderson-robert-eugene-jr-bought-24940-worth-of-shares-6293549)
- 2025-11-24 21:02 UTC [Insider Buy] [President & CEO Barry Richard bought $414,000 worth of shares (150,000 units at $2.76) (SEC Form 4)](https://www.quantisnow.com/insight/president-ceo-barry-richard-bought-414000-worth-of-shares-150000-6291701)
- 2025-11-20 22:39 UTC [Insider Buy] [President & CEO Barry Richard bought $201,809 worth of shares (73,385 units at $2.75) (SEC Form 4)](https://www.quantisnow.com/insight/president-ceo-barry-richard-bought-201809-worth-of-shares-73385-6289310)
- 2025-11-13 02:59 UTC [SEC Form S-3] [SEC Form S-3 filed by Cassava Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-cassava-sciences-inc-6275845)
- 2025-11-12 21:02 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Cassava Sciences Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-cassava-sciences-inc-6274191)
- 2025-11-12 13:10 UTC [SEC Form 8-K] [Cassava Sciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cassava-sciences-inc-filed-sec-form-8-k-results-of-operations-6273033)
- 2025-11-12 13:00 UTC [Leadership Update] [Cassava Reports Q3 2025 Financials Results and Provides Business Update](https://www.quantisnow.com/insight/cassava-reports-q3-2025-financials-results-and-provides-business-update-6272911)
- 2025-10-24 12:10 UTC [SEC Form 8-K] [Cassava Sciences Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/cassava-sciences-inc-filed-sec-form-8-k-other-events-6244147)
- 2025-10-22 22:15 UTC [SEC Form 4] [SEC Form 4 filed by Director Bir Dawn Carter](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-bir-dawn-carter-6242174)
- 2025-10-22 22:11 UTC [SEC Form 3] [SEC Form 3 filed by new insider Bir Dawn Carter](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-bir-dawn-carter-6242171)
- 2025-10-22 12:12 UTC [SEC Form 8-K] [Cassava Sciences Inc. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/cassava-sciences-inc-filed-sec-form-8-k-regulation-fd-disclosure-6241049)
- 2025-10-22 12:00 UTC [Leadership Update] [Cassava Sciences Appoints Dawn C. Bir to the Board of Directors](https://www.quantisnow.com/insight/cassava-sciences-appoints-dawn-c-bir-to-the-board-of-6240970)
- 2025-10-02 20:44 UTC [Insider Buy] [Chief Operating & Legal Office Cook Robert Christopher bought $39,940 worth of shares (13,725 units at $2.91) (SEC Form 4)](https://www.quantisnow.com/insight/chief-operating-legal-office-cook-robert-christopher-bought-39940-worth-6220646)
- 2025-09-23 20:06 UTC [Insider Buy] [President & CEO Barry Richard bought $16,352 worth of shares (7,172 units at $2.28) (SEC Form 4)](https://www.quantisnow.com/insight/president-ceo-barry-richard-bought-16352-worth-of-shares-7172-6209359)
- 2025-09-22 20:07 UTC [Insider Buy] [President & CEO Barry Richard bought $534,743 worth of shares (237,941 units at $2.25) (SEC Form 4)](https://www.quantisnow.com/insight/president-ceo-barry-richard-bought-534743-worth-of-shares-237941-6208070)
- 2025-09-08 13:15 UTC [SEC Form 8-K] [Cassava Sciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cassava-sciences-inc-filed-sec-form-8-k-regulation-fd-disclosure-6192852)
- 2025-08-25 12:00 UTC [Conference Announcement] [Cassava Sciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference](https://www.quantisnow.com/insight/cassava-sciences-to-participate-in-the-hc-wainwright-27th-annual-6177024)
- 2025-08-14 12:15 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Cassava Sciences Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-cassava-sciences-inc-6164649)
- 2025-08-14 11:45 UTC [SEC Form 8-K] [Cassava Sciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cassava-sciences-inc-filed-sec-form-8-k-results-of-operations-6164481)
- 2025-08-14 11:30 UTC [Leadership Update] [Cassava Reports Q2 2025 Financials Results and Provides Business Update](https://www.quantisnow.com/insight/cassava-reports-q2-2025-financials-results-and-provides-business-update-6164432)
- 2025-08-07 11:30 UTC [Leadership Update] [Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer](https://www.quantisnow.com/insight/cassava-sciences-appoints-dr-joseph-hulihan-as-chief-medical-officer-6152266)
- 2025-08-04 11:45 UTC [SEC Form 8-K] [Cassava Sciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cassava-sciences-inc-filed-sec-form-8-k-regulation-fd-disclosure-6143920)
- 2025-08-04 11:30 UTC [Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy](https://www.quantisnow.com/insight/cassava-sciences-reports-positive-preclinical-study-evaluating-simufilam-for-tsc-related-6143884)
- 2025-07-29 15:22 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Cassava Sciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-cassava-sciences-inc-6135871)
- 2025-07-16 20:04 UTC [SEC Form 4] [SEC Form 4 filed by Director Scannon Patrick J Md Phd](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-scannon-patrick-j-md-6122013)
- 2025-06-30 11:15 UTC [SEC Form 8-K] [Cassava Sciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cassava-sciences-inc-filed-sec-form-8-k-regulation-fd-disclosure-6102772)
- 2025-06-30 11:00 UTC [Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting](https://www.quantisnow.com/insight/cassava-presents-promising-preclinical-simufilam-data-at-tsc-alliance-meeting-6102731)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/SAVA
- Earnings history: https://www.quantisnow.com/earnings/SAVA
- Dividend history: https://www.quantisnow.com/dividends/SAVA
- Insider transactions: https://www.quantisnow.com/insiders/SAVA
- Options chain: https://www.quantisnow.com/options/SAVA
- SEC 8-K filings only: https://www.quantisnow.com/company/SAVA/8-k
- RSS and alerts for SAVA: https://www.quantisnow.com/docs/rss-feeds.md